TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,480 | -99.5% | 15,847 | -98.4% | 0.00% | -100.0% |
Q2 2023 | $24,259,143 | +1922.6% | 976,615 | +1124.6% | 0.04% | +1850.0% |
Q1 2023 | $1,199,409 | +1469.2% | 79,748 | +1134.3% | 0.00% | – |
Q4 2022 | $76,433 | +96.0% | 6,461 | -2.2% | 0.00% | – |
Q3 2022 | $39,000 | +875.0% | 6,603 | +517.1% | 0.00% | – |
Q2 2022 | $4,000 | -98.1% | 1,070 | -95.2% | 0.00% | – |
Q1 2022 | $213,000 | -52.9% | 22,411 | -5.8% | 0.00% | -100.0% |
Q4 2021 | $452,000 | – | 23,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |